It means some of your dose did not make it into the subcutaneous tissue
LegitScript is an independent auditor that vets online health services
In preclinical models, co-administration of bimagrumab or dual myostatin/activin A inhibitors with GLP-1R agonists preserves or increases muscle mass while enhancing fat loss, resulting in improved body composition and metabolic outcomes compared with GLP-1R agonist monotherapy [176]
This may offer a cheaper alternative to injectable Ozempic, as while a 3-month supply may also be available for $25, self-pay patients can expect to pay $349 per month for doses up to 1 mg and $499 for the 2 mg dose
Maintaining weight loss after tirzepatide requires deliberate strategies: established exercise habits, protein-prioritized nutrition, and in some cases, transitioning to a lower maintenance dose rather than stopping completely
It does not mandate that providers follow these exact thresholds in practice